arginine vasopressin has been researched along with nicardipine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 10 (55.56) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bicknell, RJ; Hatton, GI; Kato, M; Mason, WT | 1 |
| Marumo, F; Nonoguchi, H; Tomita, K | 2 |
| Kurokawa, K; Naruse, M; Ogata, E; Uchida, S | 1 |
| Eguchi, S; Emori, T; Hirata, Y; Imai, T; Kanno, K; Marumo, F; Ohta, K; Shichiri, M | 1 |
| Abe, K; Kanazawa, M; Sato, M; Takeuchi, K; Yasujima, M; Yoshinaga, K | 1 |
| Barlier, S; Colin, DA; Couraud, F; Dayanithi, G; Kretz-Zaepfel, M; Martin-Moutot, N; Nordmann, JJ | 1 |
| Ichikawa, M; Kumagai, H; Kumagai, K; Nishizawa, M; Ryuzaki, M; Saruta, T; Suzuki, H | 1 |
| Nordmann, JJ; Stuenkel, EL | 1 |
| Ichikawa, M; Jimbo, M; Kumagai, H; Matsumura, Y; Ryuzaki, M; Saruta, T; Suzuki, H | 1 |
| Fujihara, H; Fujiwara, N; Fukuda, S; Shimoji, K | 1 |
| Dayanithi, G; Lemos, JR; Newcomb, R; Wang, G | 1 |
| Fujita, T; Kamiya, H; Nakayama, Y; Shimohigashi, Y; Takano, Y; Tanabe, S; Tsujimoto, G | 1 |
| Brandis, M; Epting, T; Fischer-Riepe, P; Gordjani, N; Greger, RF; Leipziger, J; Nitschke, R | 1 |
| Abe, K; Egawa, T; Fujii, M; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Tsukikawa, H | 1 |
| Abe, K; Egashira, N; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Miura, I; Tsukikawa, H | 1 |
1 review(s) available for arginine vasopressin and nicardipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for arginine vasopressin and nicardipine
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Signal transduction in the neurohypophyseal compartments.
Topics: Animals; Arginine Vasopressin; Calcium; Cells, Cultured; Dynorphins; Fluorescent Dyes; Fura-2; Kinetics; Male; Microscopy, Fluorescence; Neurons; Nicardipine; Oxytocin; Peptide Fragments; Pituitary Gland, Posterior; Potassium; Rats; Receptors, Opioid, kappa; Signal Transduction | 1992 |
Inhibition of fluid transport by endothelin through protein kinase C in collecting duct of rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Arginine Vasopressin; Biological Transport; Cyclic AMP; Diglycerides; Endothelins; In Vitro Techniques; Indomethacin; Isoquinolines; Kidney Tubules, Collecting; Male; Nicardipine; Piperazines; Protein Kinase C; Rats; Rats, Inbred Strains | 1991 |
Effects of endothelin on peptide-dependent cyclic adenosine monophosphate accumulation along the nephron segments of the rat.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Methyl-3-isobutylxanthine; Animals; Arginine Vasopressin; Calcitonin; Calcium; Cyclic AMP; Endothelins; Glucagon; In Vitro Techniques; Indomethacin; Isoproterenol; Isoquinolines; Kidney Tubules; Loop of Henle; Nicardipine; Parathyroid Hormone; Peptides; Piperazines; Protein Kinase C; Rats | 1990 |
Endothelin 1 increases cell calcium in mouse collecting tubule cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arginine Vasopressin; Calcium; Dose-Response Relationship, Drug; Endothelins; In Vitro Techniques; Kidney Tubules, Collecting; Male; Mice; Nicardipine; Osmolar Concentration | 1991 |
Cellular mechanism of endothelin-1 release by angiotensin and vasopressin.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Angiotensin II; Animals; Arginine Vasopressin; Calcium; Cattle; Cells, Cultured; Diglycerides; Dose-Response Relationship, Drug; Down-Regulation; Egtazic Acid; Endothelins; Endothelium, Vascular; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Isoquinolines; Neomycin; Nicardipine; Piperazines; Protein Kinase C; Protein Kinase Inhibitors; Staurosporine | 1991 |
The effect of atrial natriuretic peptide on cytosolic free calcium in cultured vascular smooth muscle cells.
Topics: 1-Methyl-3-isobutylxanthine; Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Calcium; Cells, Cultured; Cytosol; Egtazic Acid; Ethers; Ionomycin; Kinetics; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nicardipine; Potassium Chloride; Rats; Rats, Inbred Strains | 1989 |
The calcium channel antagonist omega-conotoxin inhibits secretion from peptidergic nerve terminals.
Topics: Animals; Arginine Vasopressin; Calcium Channel Blockers; Cell Membrane; Dihydropyridines; Electric Stimulation; In Vitro Techniques; Kinetics; Male; Mollusk Venoms; Nerve Endings; Nicardipine; omega-Conotoxin GVIA; Pituitary Gland, Posterior; Potassium; Rats; Reference Values; Verapamil | 1988 |
Different responses of renal blood flow and sympathetic nerve activity to captopril and nicardipine in conscious renal hypertensive rabbits.
Topics: Analysis of Variance; Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Disease Models, Animal; Female; Heart Rate; Hypertension, Renal; Kidney; Nicardipine; Norepinephrine; Rabbits; Regional Blood Flow; Renal Circulation; Sympathetic Nervous System; Vascular Resistance; Vasodilation | 1995 |
Intracellular calcium and vasopressin release of rat isolated neurohypophysial nerve endings.
Topics: Animals; Arginine Vasopressin; Calcium; Chelating Agents; Egtazic Acid; Exocytosis; In Vitro Techniques; Intracellular Fluid; Kinetics; Male; Membrane Potentials; Nerve Endings; Nicardipine; Pituitary Gland, Posterior; Potassium; Rats; Rats, Sprague-Dawley; Rats, Wistar | 1993 |
Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Clonidine; Disease Models, Animal; Female; Hypertension, Renovascular; Kidney; Nicardipine; Norepinephrine; Rabbits; Renin-Angiotensin System; Sympathetic Nervous System | 1993 |
The effects of halothane on arginine-vasopressin-induced Ca2+ mobilization from the intracellular stores and the receptor-mediated Ca2+ entry from the extracellular space in single cultured smooth muscle cells of rat aorta.
Topics: Anesthetics, Inhalation; Animals; Aorta, Thoracic; Arginine Vasopressin; Calcium; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Extracellular Space; Halothane; Intracellular Fluid; Muscle, Smooth, Vascular; Nicardipine; Rats; Rats, Wistar; Receptors, Cell Surface; Ryanodine; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
An R-type Ca(2+) current in neurohypophysial terminals preferentially regulates oxytocin secretion.
Topics: Animals; Arginine Vasopressin; Calcium Channel Blockers; Calcium Channels, R-Type; Membrane Potentials; Nerve Endings; Nicardipine; omega-Agatoxin IVA; omega-Conotoxins; Oxytocin; Patch-Clamp Techniques; Peptides; Pituitary Gland, Posterior; Rats; Spider Venoms | 1999 |
Pharmacological characterization of a novel AVP(4-9) binding site in rat hippocampus.
Topics: Animals; Arginine Vasopressin; Binding, Competitive; Calcium; Calcium Channel Blockers; Hippocampus; Inositol 1,4,5-Trisphosphate; Male; Memory; Nicardipine; Nifedipine; omega-Conotoxins; Peptide Fragments; Radioligand Assay; Rats; Rats, Wistar; Signal Transduction; Sulfur Radioisotopes | 2000 |
Cyclosporin-A-induced effects on the free Ca2+ concentration in LLC-PK1-cells and their mechanisms.
Topics: Adenosine Triphosphate; Animals; Arginine Vasopressin; Biological Transport; Calcineurin Inhibitors; Calcium; Cyclosporine; Estrenes; Fluorescent Dyes; Fura-2; Immunosuppressive Agents; Inositol 1,4,5-Trisphosphate; Kidney Tubules, Proximal; LLC-PK1 Cells; Nicardipine; Phosphodiesterase Inhibitors; Pyrrolidinones; Renal Agents; Signal Transduction; Swine; Tacrolimus; Type C Phospholipases; Vasodilator Agents | 2000 |
Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Hemicholinium 3; Hippocampus; Hormone Antagonists; Injections, Intraventricular; Male; Maze Learning; Memory; Memory Disorders; Neurotransmitter Uptake Inhibitors; Nicardipine; Peptide Fragments; Pirenzepine; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine | 2001 |
Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinases; Cholinergic Antagonists; Maze Learning; Memory; Microdialysis; Nicardipine; Nootropic Agents; Oligopeptides; Pirenzepine; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine | 2003 |